Innovative Concepts for Pharmacological Treatment of Cardiac Arrhythmias
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (29 October 2021)
Special Issue Editors
Interests: cardiac electrophysiology; experimental models on cardiac arrhythmias; catheter ablation; implantable devices
Special Issue Information
Dear Colleagues,
I would like to inform you that the Pharmaceuticals Special Issue “Innovative Concepts for Pharmacological Treatment of Cardiac Arrhythmia” is now accepting manuscripts for publication. Pharmacological treatment of cardiac arrhythmias still represents a challenge, as the number of available antiarrhythmic agents is limited to a few compounds. In particular, in the presence of chronic heart failure, antiarrhythmic drug therapy is mainly limited to amiodarone. Therefore, development of new compounds as well as identification of antiarrhythmic properties of non-cardiovascular drugs is an important topic for future development of cardiovascular therapies. Contributions to this issue include submission of original articles, review, short communications, and editorials.
Prof. Dr. Gerrit Frommeyer
Dr. Christian Ellermann
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiarrhythmic drugs
- ventricular arrhythmias
- atrial fibrillation
- sudden cardiac death
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
